The EU Commission clears a merger, subject to remedies, in the pharmaceutical sector (Meda / Mylan)

Mergers: Commission clears acquisition of Meda by Mylan subject to conditions* The European Commission has approved under the EU Merger Regulation the proposed acquisition of Meda AB of Sweden by Mylan N.V. of the Netherlands, subject to conditions. Both companies operate in the pharmaceutical sector. The decision is conditional upon the divestment of a number of Mylan's or Meda's businesses in Austria, Belgium, Estonia, France, Luxembourg, Ireland, Italy, Norway, Portugal, Spain and the UK. The Commission had concerns

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

European Commission, The EU Commission clears a merger, subject to remedies, in the pharmaceutical sector (Meda / Mylan), 20 July 2016, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 80285

Visites 125

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues